LGD 4033 Ligandrol Capsules

Buy LGD 4033 Ligandrol Capsules Online

LGD-4033, commonly called Ligandrol, is a potent nonsteroidal selective androgen receptor modulator studied extensively for its effects on androgen-receptor signaling and lean body mass.

Product Information

LGD-4033 was developed to produce selective anabolic activity in muscle and bone. Human clinical research has evaluated its pharmacokinetics, tolerability, body-composition effects, and endocrine responses. LGD-4033 is also known as Ligandrol and is sometimes abbreviated as LGD.

How It Works

Ligandrol binds strongly to androgen receptors, activating signaling involved in muscle and other androgen-responsive tissues. Human research has demonstrated dose-dependent effects on lean body mass as well as suppression of several endogenous hormones.

POTENTIAL BENEFITS

1. Lean-Mass Research

Controlled human research has demonstrated increases in lean body mass during short-term LGD-4033 administration, making it one of the better-characterized SARMs in human research.

2. Androgen-Receptor Research

LGD-4033 provides a useful model for investigating selective androgen-receptor activation and how receptor signaling affects muscle and other tissues.

3. Muscle-Strength Research

Clinical investigations have examined changes in muscle-related physical performance alongside body-composition changes, providing useful data for anabolic research.

4. Pharmacokinetic Research

LGD-4033 has a relatively long elimination half-life and demonstrates dose-proportional accumulation, making it particularly useful for studying repeated-dose SARM pharmacology.

Dosage

A randomized human trial evaluated 0.1 mg, 0.3 mg, and 1.0 mg once daily for 21 days. The study found dose-dependent increases in lean body mass but also dose-dependent suppression of total testosterone, SHBG, and HDL cholesterol. These were controlled clinical-study doses, not a recommendation for unsupervised use.

Side Effects

Human research has demonstrated suppression of endogenous testosterone and changes in SHBG and HDL cholesterol. Case reports have also documented serious liver injury associated with non-medical LGD-4033 use.

References

1. Basaria et al. — The safety, pharmacokinetics, and effects of LGD-4033 in healthy young men. Journal of Gerontology: Series A, 2013. PMID: 22459616
2. Schulte et al. — Ligandrol (LGD-4033)-Induced Liver Injury. Clinical Journal of Gastroenterology, 2020. PMID: 32637435
3. PubMed — LGD-4033 clinical and analytical research

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.